These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24068544)

  • 1. Evaluation of MAGE-D4 expression in hepatocellular carcinoma in Japanese patients.
    Takami H; Kanda M; Oya H; Hibino S; Sugimoto H; Suenaga M; Yamada S; Nishikawa Y; Asai M; Fujii T; Nomoto S; Kodera Y
    J Surg Oncol; 2013 Dec; 108(8):557-62. PubMed ID: 24068544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Melanoma antigen-1 mRNA combined with alpha-fetoprotein mRNA levels in peripheral blood of patients with hepatocellular carcinoma: a predictor of postoperative recurrence or metastasis?
    Zhang Y; Song T; Meng L; Wu X; Ba Y; Li Q
    ANZ J Surg; 2009; 79(1-2):62-9. PubMed ID: 19183381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Overexpression of melanoma-associated antigen D4 is an independent prognostic factor in squamous cell carcinoma of the esophagus.
    Oya H; Kanda M; Takami H; Hibino S; Shimizu D; Niwa Y; Koike M; Nomoto S; Yamada S; Nishikawa Y; Asai M; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Dis Esophagus; 2015; 28(2):188-95. PubMed ID: 24147998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of MAGE genes and survival in patients with hepatocellular carcinoma.
    Suzuki K; Tsujitani S; Konishi I; Yamaguchi Y; Hirooka Y; Kaibara N
    Int J Oncol; 1999 Dec; 15(6):1227-32. PubMed ID: 10568832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression and frequently humoral immune response of melanoma-associated antigen D4 in glioma.
    He SJ; Gu YY; Yu L; Luo B; Fan R; Lin WZ; Lan XW; Lin YD; Zhang QM; Xiao SW; Xie XX
    Int J Clin Exp Pathol; 2014; 7(5):2350-60. PubMed ID: 24966945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of phosphatidylinositol 4-kinase type IIIα is associated with undifferentiated status and poor prognosis of human hepatocellular carcinoma.
    Ilboudo A; Nault JC; Dubois-Pot-Schneider H; Corlu A; Zucman-Rossi J; Samson M; Le Seyec J
    BMC Cancer; 2014 Jan; 14():7. PubMed ID: 24393405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival.
    Guo X; Xiong L; Zou L; Sun T; Zhang J; Li H; Peng R; Zhao J
    Diagn Pathol; 2012 Aug; 7():96. PubMed ID: 22888955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
    Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
    Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of MAGE-D4 in colorectal cancer is a potentially prognostic biomarker and immunotherapy target.
    Zhang QM; He SJ; Shen N; Luo B; Fan R; Fu J; Luo GR; Zhou SF; Xiao SW; Xie XX
    Int J Clin Exp Pathol; 2014; 7(7):3918-27. PubMed ID: 25120768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.
    Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X
    Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of serum melanoma-associated antigen D4 in patients with squamous cell carcinoma of the esophagus.
    Oya H; Kanda M; Koike M; Iwata N; Niwa Y; Shimizu D; Takami H; Sueoka S; Hashimoto R; Ezaka K; Nomoto S; Yamada S; Fujii T; Nakayama G; Sugimoto H; Fujiwara M; Kodera Y
    Dis Esophagus; 2016 Aug; 29(6):663-9. PubMed ID: 25951896
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Melanoma antigen-3 expression in human hepatocellular carcinoma].
    Cai S; Zhao H; Leng X; Cheng J; Gong S; Peng J; Cong X; Wang Y; Rui J; Hui Y; Du R; Chen W
    Zhonghua Wai Ke Za Zhi; 2000 Sep; 38(9):693-6. PubMed ID: 11832142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
    Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
    Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. NGAL and NGALR overexpression in human hepatocellular carcinoma toward a molecular prognostic classification.
    Zhang Y; Fan Y; Mei Z
    Cancer Epidemiol; 2012 Oct; 36(5):e294-9. PubMed ID: 22728279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High alpha-fetoprotein level correlates with high stage, early recurrence and poor prognosis of hepatocellular carcinoma: significance of hepatitis virus infection, age, p53 and beta-catenin mutations.
    Peng SY; Chen WJ; Lai PL; Jeng YM; Sheu JC; Hsu HC
    Int J Cancer; 2004 Oct; 112(1):44-50. PubMed ID: 15305374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of MAGE-1, MAGE-3 and AFP mRNA as multimarker by real-time quantitative PCR assay: a possible predictor of hematogenous micrometastasis of hepatocellular carcinoma.
    Zhang Y; Li Q; Liu N; Song T; Liu Z; Guo R; Meng L
    Hepatogastroenterology; 2008; 55(88):2200-6. PubMed ID: 19260505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Detection of alpha-fetoproteins mRNA and melanoma antigen-1 mRNA in peripheral blood of patients with hepatocellular carcinoma and its clinical significance].
    Yang SZ; Dong JH; Zhu J; Li K; Zhang Y
    Zhonghua Wai Ke Za Zhi; 2004 Sep; 42(17):1060-3. PubMed ID: 15498320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of MAGE-1 and MAGE-3 as tumour-specific markers to detect blood dissemination of hepatocellular carcinoma cells.
    Mou DC; Cai SL; Peng JR; Wang Y; Chen HS; Pang XW; Leng XS; Chen WF
    Br J Cancer; 2002 Jan; 86(1):110-6. PubMed ID: 11857021
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overexpression of NDRG1 is an indicator of poor prognosis in hepatocellular carcinoma.
    Chua MS; Sun H; Cheung ST; Mason V; Higgins J; Ross DT; Fan ST; So S
    Mod Pathol; 2007 Jan; 20(1):76-83. PubMed ID: 17170744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.